Dream Caps aims to provide hope, confidence to children battling cancer

“There are no words to describe that day. It’s a traumatic day. It’s a traumatic experience,” said Liane Sanchez.

At the age of six, Liane’s son, Chris, was diagnosed with acute lymphoblastic leukemia.

“It was like seeing myself from a distance, and everything was surreal. I looked at him and didn’t know what was going on that day. It took a while for him to feel better, to be able to explain to him what was going on and what he can expect in the coming years,” said Liane.

During his treatment Chris lost his hair. Liane said most days; he would wear a cap outdoors.

“Losing your hair, you know. Chris is a tough guy, really as tough as they come. Hair wasn’t a big deal; we didn’t make a big deal out of it in our family. We rejoiced because it was a sign that the chemotherapy was working , but it’s a visual reminder of everything his little body is going through,” she said.

Chris was originally scheduled to complete treatment in January 2022, but based on favorable results; he completed treatment a year earlier than expected. Chris is now in remission.

“He responded very well to the chemo treatment and was characterized as in remission within 30 days,” Liane said.

When he was done with the treatment, Chris’ sister Aneli got the idea to make hats for children fighting the same battle. Then Dream Caps was born.

“Chris really has a knack for colors and styles. So he helps with the hats and design. My daughter, she helped with a lot of the sayings and the logos,” said Liane.

Each hat inspires children battling cancer to stay hopeful and dream big.

“What I love most about dream hats is that I love helping people and reminding them to follow their dreams,” Chris says.

“I think it’s important to make hats in the hope of putting a smile on their faces,” Aneli said.

Liane said that with every purchase, a hat is donated to a child battling cancer.

For more information, visit dream-caps.com.

Melissa Marrero at WSFL first reported this story.

Comments are closed.